Isn’t DAC cheaper? Or us it more expensive in the UK ?

I am interested re health authorities. They ‘may’ offer 8 weeks of something or the other in the UK, so you could top it up with an extra bottle if waiting for that eg? Just wondered why if DAC is cheaper to them, why it’s all about Harvoni for GT1s and talk of DAC as being expensive when I’ve read it’s cheaper.

Ah – How typical of English bureaucracy !

My take on this is that it’s a result of Gilead machinations.

Gilead has been unwilling to participate with Bristol-Myers Squibb to get approval of the Sof/Dac combo in the US except on treating G3 … not in their financial interest, as Ledipasvir is a Gilead product. Gilead has been spending heavily on Harvoni ads, and most of the press and awareness in the US is all about Gilead’s products. Many doctors in other countries are following the US standard recommendations, for example my hepatologist in Thailand.

Therefore the Chinese entities such as Mesochem likely perceive a greater demand and price inelasticity with the ledipasvir … and they simply price accordingly.

When the Indian companies get approved with their Harvoni generic equivalents expect a price crash on the Led from China.

But I still think it’s crazy to wait.

And I personally think the Dac is better and have chosen accordingly …. BUT I’M NOT A DOCTOR.

Perhaps NHS is planning to negotiate a better price for the Dac? I’ve heard that Bristol Mayers reporting a loss. Russia managed to negotiate a very good price for the Dac. £1.2K per bottle. That’s less than £4k for the course of 12 weeks!